Market Research Insights

According to a report by Grand View Research, Inc., the stem cell market was valued at USD 8.65 billion in 2018 and is projected to exhibit a healthy CAGR of 8.8% throughout the forecast period (2019-2025). Technological progressions in stem cell manufacturing & preservation and growing public consciousness about the therapeutic potency of the product are likely to drive the market in the forecast period. In addition, rising private-public funding and investment in stem cell-based research and consciousness about the therapeutic effects of stem cell products are anticipated to boost the market throughout the forecast period. The factors like rising government support for stem cell therapeutics in Europe and U.S. and growth of innovative genomic analysis techniques for quality control in the stem cell production are expected to propel the market. On the other hand, substantial operational prices associated with stem cell manufacturing, banking, and long approval processes are lik

San Francisco, 5 March 2019: The Report Stem Cells Market Analysis By Product (Adult Stem Cells, hESC, Induced Pluripotent Stem Cells), By Application (Regenerative Medicine, Drug Discovery), By Technology, By Therapy, And Segment Forecasts, 2018 – 2025 The global Stem Cells Market is expected to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%, according to a new report by Grand View Research, Inc. Augmentation in research studies that aim at broadening the utility scope of associated products is anticipated to drive the market growth. These research projects have opened the possibility of implementation of several clinical applications of these cells, thereby impacting disease-modifying treatments. Scientists are engaged in discovering novel methods to create human stem cells. This is to address the increasing demand for stem cell production for potential investigation in disease management. This factor is certainly expected to accelerate the development of regenerative